Our old friend Steve Freedland.
"Men had to have a BMI >=24 kg/m2, received radical prostatectomy or definitive local radiation for PC, had a PSA 0.4-20.0 ng/ml (3-20 if prior radiation therapy) within the past 3 months, and current PSADT 3-36 months. The intervention arm was instructed to eat , 20 grams/carbs/day with no other limits."
Eat all you want but not carbs.
"Six months on the low carb diet resulted in greater weight loss (median: 31.7 vs. 0.8 lbs"
"Whether this weight loss slows PC growth is an on-going question."
My guess is that weight loss will slow PCa, since there must be a score of studies that associate high BMI with aggressive disease & faster progression.
The men did eat more fat, but the biggest increase was in protein (125 vs. 73 g), which I doubt is a good idea.
382 Poster Session (Board #F7), Fri, 12:15 PM-1:45 PM and
6:00 PM-7:00 PM
Interim analysis of a prospective randomized trial of dietary carbohydrate restriction for men with a rising PSA after failed primary treatment: Carbohydrate and Prostate Study 2 (CAPS2).
Stephen J. Freedland, Jenifer Allen, Andrew J. Armstrong, Judd W. Moul, Howard M. Sandler, Dana Levin, Lauren E. Howard, Pao-hwa Lin; Cedars-Sinai Medical Center, Los Angeles, CA; Duke University, Durham, NC; Duke Cancer Institute, Duke University, Durham, NC; Cedars-Sinai, Los Angeles, CA; Durham VA Medical Center/ Duke University, Durham, NC
Background: Nearly one third of men treated with curative intent for localized prostate cancer (PC) will develop a rising PSA. The rate of PSA rise (PSA doubling time aka PSASDT) is a predictor metastases and PC death. In laboratory mice, an extreme low carbohydrate diet slows PC growth. We tested whether this diet could slow PSADT in men with recurrent PC.
Methods: We are conducting a 6-month multi-center randomized phase II trial of dietary carbohydrate restriction vs. no diet intervention control. Men had to have a BMI $24 kg/m2, received radical prostatectomy or definitive local radiation for PC, had a PSA 0.4-20.0 ng/ml (3-20 if prior radiation therapy) within the past 3 months, and current PSADT 3-36 months. The intervention arm was instructed to eat , 20 grams/carbs/day with no other limits. The control arm was told to make no diet. In this interim analysis, we present the efficacy of the dietary intervention with regards to weight loss. Arms were compared using rank-sum. Total anticipated enrollment is 60. The primary outcome is differences in PSADT between arms. Secondary outcomes include weight loss, and dietary make-up.
Results: To date, 28 patients (14 in each study arm) have completed the study. Characteristics were well- balanced at baseline. At the 6-month dietary assessment, calorie consumption was similar between the two study arms (p = 0.090) among the 16 patients (7 low-carb, 9 control) with diet information. Subjects in the low-carb arm ate fewer carbs (29 vs. 188 g, p = 0.008) and more protein (125 vs. 73 g, p = 0.044) but similar amounts of fat (75 vs. 67 g, p = 0.672) vs. subjects in the control arm. Six months on the low carb diet resulted in greater weight loss (median: 31.7 vs. 0.8 lbs, p , 0.001), lower BMI (24.4 vs. 29.6 kg/m2, p , 0.001), and smaller waist circumference (95.7 vs. 108.9 cm, p = 0.002).
Conclusions: In this interim analysis of an on-going dietary study for men with a rising PSA after definitive local treatment, an extreme low carbohydrate diet results in dramatic weight loss in 6 months. Whether this weight loss slows PC growth is an on-going question. Clinical trial information: NCT01763944.